Nuwellis, Inc., based in Eden Prairie, Minnesota with 70 employees, specializes in developing and commercializing the Aquadex System, which includes devices like Aquadex SmartFlow and Aquadex FlexFlow for ultrafiltration therapy in patients unresponsive to other treatments. The company, which went public in 2012, aims its products at adults and pediatric patients over 20 kilograms suffering from fluid overload who have not responded to diuretic therapy.
Nuwellis (NUWE) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Nuwellis's actual EPS was -$18.85, missing the estimate of -$8.41 per share, resulting in a -124.14% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.